MétaCan
Menu
Back to cohort
Record W3037804099 · doi:10.1056/nejmoa1916624

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes

2020· article· en· W3037804099 on OpenAlexaff
Alessandro Doria, Andrzej T. Gałecki, Cathie Spino, Rodica Pop‐Busui, David Z.I. Cherney, Ildiko Lingvay, Afshin Parsa, Peter Rossing, Ronald J. Sigal, Maryam Afkarian, Ronnie Aronson, Maria Luiza Caramori, Jill P. Crandall, Ian H. de Boer, Thomas G. Elliott, Allison B. Goldfine, J. Sonya Haw, Irl B. Hirsch, Amy B. Karger, David M. Maahs, Janet B. McGill, Mark E. Molitch, Bruce A. Perkins, Sarit Polsky, Marlon Pragnell, William N. Robiner, Sylvia E. Rosas, Peter Senior, Katherine R. Tuttle, Guillermo E. Umpierrez, Amisha Wallia, Ruth S. Weinstock, Chun-Yi Wu, Michael Mauer

Bibliographic record

VenueNew England Journal of Medicine · 2020
Typearticle
Languageen
FieldMedicine
TopicGout, Hyperuricemia, Uric Acid
Canadian institutionsUniversity of AlbertaLMC Diabetes & Endocrinology (Canada)Lunenfeld-Tanenbaum Research InstituteUniversity of CalgaryUniversity of TorontoUniversity Health Network
FundersNational Center for Advancing Translational SciencesNational Institute on AgingNational Institutes of HealthSteno Diabetes Center CopenhagenNational Institute of Diabetes and Digestive and Kidney DiseasesJuvenile Diabetes Research Foundation United States of America
KeywordsAllopurinolRenal functionType 2 diabetesMedicineGoutHyperuricemiaInternal medicineUric acidDiabetes mellitusEndocrinologyCardiology

Abstract

fetched live from OpenAlex

BACKGROUND: Higher serum urate levels are associated with an increased risk of diabetic kidney disease. Lowering of the serum urate level with allopurinol may slow the decrease in the glomerular filtration rate (GFR) in persons with type 1 diabetes and early-to-moderate diabetic kidney disease. METHODS: of body-surface area, and evidence of diabetic kidney disease to receive allopurinol or placebo. The primary outcome was the baseline-adjusted GFR, as measured with iohexol, after 3 years plus a 2-month washout period. Secondary outcomes included the decrease in the iohexol-based GFR per year and the urinary albumin excretion rate after washout. Safety was also assessed. RESULTS: per year; 95% CI, -1.5 to 0.4). The mean urinary albumin excretion rate after washout was 40% (95% CI, 0 to 80) higher with allopurinol than with placebo. The frequency of serious adverse events was similar in the two groups. CONCLUSIONS: We found no evidence of clinically meaningful benefits of serum urate reduction with allopurinol on kidney outcomes among patients with type 1 diabetes and early-to-moderate diabetic kidney disease. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; PERL ClinicalTrials.gov number, NCT02017171.).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.008
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.004
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.008
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.228
Teacher spread0.213 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations357
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueNew England Journal of MedicineSame topicGout, Hyperuricemia, Uric AcidFrench-language works237,207